Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-16
2007-10-16
Saunders, David A. (Department: 1644)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S395000, C530S396000, C530S399000, C530S402000, C530S404000, C530S408000, C530S411000
Reexamination Certificate
active
11285798
ABSTRACT:
A heparin-binding protein functionalized by covalently bonding thereto a sugar chain, a method for producing the protein and a pharmaceutical composition containing the protein as an active ingredient, as well as a method of functionalizing a natural protein having no sugar chain by covalently bonding thereto a sugar chain.
REFERENCES:
patent: 4280953 (1981-07-01), Guillemin et al.
patent: 4478746 (1984-10-01), Kim et al.
patent: 5360896 (1994-11-01), Senoo et al.
patent: 5486599 (1996-01-01), Saunders et al.
patent: 7005415 (2006-02-01), Imamura et al.
patent: WO8801647 (1988-03-01), None
patent: WO9116335 (1991-10-01), None
Jaye et al., Science vol. 233, pp. 541-544, Aug. 1986.
Imamura, et al., Science, vol. 249, pp. 1567-1570, Sep. 1990.
Asada Chie
Asada Masahiro
Imamura Toru
Kojima Tetsuhito
Miyakawa Kazuko
Davidson Davidson & Kappel LLC
Director--General of Agency of Industrial Science and Technology
Saunders David A.
LandOfFree
Heparin-binding proteins modified with sugar chains, method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparin-binding proteins modified with sugar chains, method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin-binding proteins modified with sugar chains, method... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3862951